ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Lorus Therapeutics


Include trials that are no longer recruiting patients.

2 studies were found.
1.RecruitingCapecitabine Plus GTI-2040 in Treating Patients With Advanced or Metastatic Renal Cell Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer
2.RecruitingCombination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell; Metastases, Neoplasm

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act